fingolimod hydrochloride has been researched along with fluorides in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (fluorides) | Trials (fluorides) | Recent Studies (post-2010) (fluorides) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 27,843 | 1,456 | 6,401 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bittman, R; Camp, SM; Chiang, ET; Dudek, SM; Garcia, JG; Natarajan, V; Sun, C; Usatyuk, PV | 1 |
1 other study(ies) available for fingolimod hydrochloride and fluorides
| Article | Year |
|---|---|
Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.
Topics: Calcium; Cell Line; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Fluorides; Glucuronides; Humans; Lysophospholipids; Microscopy, Fluorescence; Permeability; Phosphorylation; Pulmonary Artery; Signal Transduction; Sphingosine | 2015 |